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ABSTRACT
OBJECTIVE: To verify the prevalence of chronic kidney disease and the factors associated to 
it in older adults (≥ 60 years). 
METHODS: This is a population-based research conducted in 2014, involving 1,016 older adults 
living in urban and rural areas of the municipality of Rio Branco, Acre. Chronic kidney disease 
was defined by glomerular filtration rate < 60 ml/min/1.73 m², estimated by the equations of 
the Chronic Kidney Disease Epidemiology Collaboration, and the presence of albuminuria 
> 29 mg/g. Association measure were estimated by gross and adjusted odds ratio (OR), with a 
confidence level of 95% (95%CI).
RESULTS: The overall prevalence of chronic kidney disease was 21.4% in older adults, with 
the associated factors age, diabetes (OR = 3.39; 95%CI 2.13–5.40), metabolic syndrome 
(OR = 2.49; 95%CI 1.71–3.63), self-assessment of poor health (OR = 1.79; 95%CI 1.10–2.91), arterial 
hypertension (OR = 1.82; 95%CI 1.04–3.19) and obesity (OR = 1.69; 95%CI 1.02–2.80). 
CONCLUSIONS: The prevalence of chronic kidney disease was high in older adults, being 
associated with age, self-assessment of health as bad or very bad, obesity, diabetes and 
metabolic syndrome.
DESCRIPTORS: Aged. Renal Insufficiency, Chronic, epidemiology. Risk Factors. Comorbidity. 
Health Surveys.
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INTRODUCTION
The pattern of morbimortality due to chronic kidney disease (CKD) in underdeveloped and 
developing countries is changing due to the transition of infectious diseases to chronic 
non-communicable diseases1. Prevalence projections of CKD in the U.S. for 2020 and 2030, 
between individuals over 30 years, estimate that the disease will go from 13.2% in 2010 to 
14.4% in 2020 and to 16.7% in 20302.
The prevalence of CKD changes with age, reaching higher values among older people, and 
may vary from 25.1% in Nicaragua, in the age group of 60 to 70 years3, to 30.8% in Canada, 
among those aged ≥ 65 years4. The reduction in the glomerular filtration rate (GFR) for less 
than 60 ml/min/1.73 m² might be attributed to aging, which causes progressive structural 
and functional changes in the kidneys, or as consequence of the presence of comorbidities 
and of the exposition of risk factors throughout life5.
Among older adults, the presence of CKD represents an increased risk for multiple events 
adverse to health that may culminate in death, and the early detection of the reduced GFR 
and albuminuria is important to assist in the therapeutic decision-making and consequent 
reduction of complications6. Thus, this study aimed to estimate the prevalence of CKD and 
the factors associated to it in older adults (60 years or more), using part of the data from 
the Estudo das Doenças Crônicas (Edoc – Study of Chronic Diseases).
METHODS
The Edoc is composed of two household surveys: the Edoc-A, on adults (18 to 59 years-old), 
and the Edoc-I, on older adults (60 years or more), all living in Rio Branco, Acre. Individuals 
with cognitive impairments that could preclude communication or understanding of the 
questions were excluded. Sampling plans were selected in two stages, census enumerations 
areas (CEAs) and households, being the first common to the two researches. The CEAs 
were selected with probability proportional to the number of private households in the 
2010 Demographic Census (CD2010) of the Brazilian Institute of Geography and Statistics 
(IBGE). The households were selected by systematic sampling with random starts and 
distinct ranges per survey. In the households selected for Edoc-I, all the older adult residents 
were interviewed.
The sample size was estimated considering the prevalence of renal function changes of 40% 
in older adults7, with confidence level of 95% and absolute error of 3% for the simple random 
sampling of proportions. Considering that the sampling plan is conglomerated by CEA, 
a sampling plan effect of 1.95 was arbitrated to determine the sample size, which received 
an increase of 12.5% to compensate the expected non-responses. This procedure resulted 
in a sample of 1,148 older adults. By dividing this sample size by the number of older adults 
per household, according to CD2010, and by defining the selection of 73 households per 
CEA, a sample size of CEAs of 40 was obtained. The effective sample was 1,016 older adults.
The sampling weights were calculated by the inverse of the inclusion probabilities in each 
stage and were subsequently calibrated for populational data by sex and age groups, using 
a post-stratification estimator, in order to address these typical biases of the household 
surveys and to correct differential non-responses8. The population data used in the 
calibration of the sampling weights were estimated for July 1, 2014, using the linear trend 
method9 that the IBGE applies in its population estimations per municipality. This study 
included all who performed laboratory assessments of serum creatinine, that is, 983 older 
adults (578 women and 405 men), that correspond to a subsample of complete information on 
the topic. For more details about the sampling plan of the Edoc, estimation and calibration 
of sample weights and subsamples, see the article by Amaral et al.10.
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A total of 33 participants were excluded from the analysis of renal function due to the lack 
of information on serum creatinine. Each household with a participant resident filled a form 
containing general information on housing, sanitation and family. Individually, a structured 
form was used in thematic modules with socioeconomic, demographic, behavioral and 
health information.
In the physical assessment, the anthropometric data included the measurement of weight, 
height and circumferences of the waist, hips, arm and calf, all in duplicate, and the average 
of the measurements was considered.
Blood pressure (BP) was measured according to the protocol recommended by the Brazilian 
Society of Cardiology, which recommends measuring 30 minutes or more after the last drank 
dose of caffeine or smoked cigarette, in triplicate: one after five minutes of initial rest and 
two others in intervals of two minutes11.
The biological material was analyzed in the same laboratory to ensure the standardization of 
methods. Blood samples were obtained by peripheral blood collection, with prior antisepsis 
of the antecubital fossa of the participants. The serum extracted was stored for biochemical 
dosage of triglycerides, total cholesterol and fractions: high-density lipoprotein (HDL) and 
low-density lipoprotein (LDL). Serum creatinine was dosed by traceable enzymatic method 
of isotope dilution mass spectrometry (IDMS) in an automatic analyzer (Labmax 240 
Premium). To analyze serum glycemia, a 4 ml blood sample was used, stored in a vacuum 
tube containing 2 mg/ml of sodium fluoride centrifuged before analysis. The serum glycemia 
was dosed by the glucose oxidase method (Labtest Diagnostica).
For the urine sample, 50 ml of the midstream of first morning urine of each individual 
were collected, subsequently processed for physicochemical and microscopic analysis of 
the sediment.
Urinary creatinine was dosed by the enzymatic Trinder method (Kit Creatinina Enzimática, 
Labtest), and albuminuria by the immunoturbidimetric method (Kit Turbiquest Plus, 
Labtest). Albuminuria is defined with a ratio of albumin to creatinine of 30 mg/g or more, 
being the value of 30 to 299 considered A2, or moderately increased, and the value ≥ 300 mg/g 
considered A3, or markedly increased.
The systemic arterial hypertension (SAH) was defined as diastolic blood pressure 
(DBP) ≥ 90 mmHg, systolic blood pressure (SBP) ≥ 140 mmHg and/or current use of 
anti-hypertensive medication11.
The presence of diabetes was defined according to the criteria of the American Diabetes 
Association (ADA): fasting plasma glucose ≥ 126 mg/dL or use of oral hypoglycemic 
or insulin12.
Dyslipidemia was defined by abnormal levels of one or more of the following lipid blood 
components: triglycerides ≥ 150 mg/dL, total cholesterol ≥ 200 mg/dL, LDL ≥ 160 mg/dL, HDL 
in men < 40 mg/dL and in women < 50 mg/dL, in addition to the history of use of medications to 
reduce these values. For individuals aged less than 20 years, the cut-off points are: triglycerides 
≥ 130 mg/dL, total cholesterol ≥ 170 mg/dL, LDL ≥ 130 mg/dL and HDL ≤ 45 mg/dL13.
For the diagnosis of metabolic syndrome (MS), the I Brazilian Guideline of Diagnosis 
and Treatment of Metabolic Syndrome was used, which requires the presence of at 
least three of the following elements: waist diameter > 102 cm for men and > 88 cm for 
women; triglycerides ≥ 150 mg/dL; HDL < 40 mg/dL for men and < 50 mg/dL for women; 
SBP ≥ 130 mmHg, DBP ≥ 85 mmHg or use of anti-hypertensive; fasting glycemia ≥ 110 mg/dL 
or use of hypoglycemic14. 
The dependent variable of the study (CKD) was defined according to the formulas of the Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI), when GFR < 60 ml/min/1.73 m² 
and/or albuminuria > 29 mg/g15.
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The use of equations to estimate the GFR provides adjustments for the substantial 
variations regarding sex, age, body surface and ethnicity, characteristics that interfere in 
the production of creatinine. To this end, the validated equations of the Chronic Kidney 
Disease Epidemiology Collaboration (CKD-EPI) were used, described below:
Female:
Black skin color ≤ 0.7 = 166 × (serum creatinine/0.7)-0.329 × 0.993age
Black skin color > 0.7 = 166 × (serum creatinine/0.7)-1.209 × 0.993age
White skin color ≤ 0.7 = 144 × (serum creatinine/0.7)-0.329 × 0.993age
White skin color > 0.7 = 144 × (serum creatinine/0.7)-1.209 × 0.993age
Male:
Black skin color ≤ 0.9 = 163 × (serum creatinine/0.9)-0.411 × 0.993age
Black skin color > 0.9 = 163 × (serum creatinine/0.9)-1.209 × 0.993age
White skin color ≤ 0.9 = 141 × (serum creatinine/0.9)-0.411 × 0.993age
White skin color > 0.9 = 141 × (serum creatinine/0.9)-1.209 × 0.993age
The category “black skin color” included the individuals who self-declared black or brown.
In 2012, the categories of risk were defined for the progression of chronic kidney 
disease based on serum creatinine, with correction by formulas for obtaining GFR, 
and in albuminuria. In addition, the stage 3 of the CKD was divided in 3a and 3b. 
An important emphasis of the guidelines is the adoption of categories of CKD prognosis, 
classifying from low to high risk of progression of the acute renal injury for CKD and 
other complications15.
The data was analyzed using the Complex samples routines of the Statistical Package for the 
Social Sciences software (SPSS), version 20.0, for Windows. The natural weight of the design, 
the sample selection stratum, the primary sampling unit code (CEA) and the calibrated 
weight were maintained in the data files.
The data were analyzed in a descriptive and exploratory way to assess the distribution and 
characterize the studied population. The qualitative variables were described in absolute 
numbers and proportions. To analyze the differences between categorical variables, we used 
Pearson’s chi-squared test.
A bivariate analysis was also performed in order to explore the association of the different 
variables with the object of study. Models of odds ratio estimated the magnitude of 
association between the dependent variable CKD and the independent variables. For 
multiple analysis, the variables included were the ones that showed a p value lower than 0.10 
in the crude analysis, and the magnitude of the variables adjusted by the other significant 
variables was analyzed. The backward method was used in the selection of the variables in 
the multivariate analysis. Age and sex interactions with CKD were tested, with no effect 
changes observed. The significance level considered was α = 0.05.
All analysis considered the effect of the sampling design and the calibrated weights 
of the observations, and the results of the observations are demonstrated by “n” and 
the results considering the calibrated weights for extrapolation for the population by 
“expanded n (N)”. To this end, the pseudo maximum likelihood method (PML) was used, 
considering the sampling weights and the structural information of the sampling plan. 
The interferences were assessed by Wald statistics based on the sampling plan, along 
with the F distribution.
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Table 1. Prevalence by category of risk of the prognosis of CKD evolution assessed by GFR (estimated by the CKD-EPI formula) and albuminuria 
in older adults from Rio Branco, state of Acre, 2014.
Categories of risk 
of CKD
Total
Albuminuria CKD  
(GFR* and albuminuria)A1 (< 30) A2 (30–299) A3 (≥ 300)
n N (%) n N (%) n Exp N (%) n N (%) n N (%)
1 ≥ 90 296 7,982 (34.0) 270a 7,252 (31.2)a 19b 518 (2.2)b 4c 116 (0.5)c 23 634 (2.7)
2 60–89 547 12,407 (53.0) 486a 10,982 (47.3)a 45b 1,059 (4.6)b 11c 260 (1.1)c 56 1,319 (5.7)
3a 45–59 106 2,271 (9.7) 85b 1,778 (7.7) 15c 358 (1.6)c 6d 135 (0.6)d 106 2,217 (9.7)
3b 30–44 26 552 (2.4) 19c 385 (1.7)c 4d 93 (0.4)d 3d 73 (0.3)d 26 552 (2.4)
4 15–29 4 93 (0.4) 4d 93 (0.4)d - - - - 4 93 (0.4)
5 < 15 4 111 (0.5) 1d 24 (0.1)d 2d 54 (0.2)d 1d 33 (0.1)d 4 111 (0.5)
Total 983 23,416 (100.0) 865 20,514 (88.4) 85 2,082 (9.0) 25 617 (2.6) 219 4,979 (21.4)
N: expanded n from sampling weights and design; %: proportion from N; CKD: chronic kidney disease; GFR: glomerular filtration rate 










n N n N % n N %
Sex 0.519
Female 577 12,496 123 2,570 20.6 454 9,926 79.4
Male 406 10,920 96 2,409 22.1 310 8,511 77.9
Age group (years) < 0.001
60–69 475 13,394 75 2,134 15.9 400 11,260 84.1
70–79 339 6,687 80 1,586 23.7 259 5,101 76.3
80 and more 169 3,335 64 1,259 37.8 105 2,076 62.2
Skin color 0.158
White 241 5,601 62 1,374 24.5 179 4,227 75.5
Brown 634 15,221 140 3,217 21.1 494 12,004 78.9
Other 108 2,594 17 388 15.0 91 2,206 85.0
Education level* 0.804
Higher education 38 954 10 231 24.2 28 723 75.8
High school 112 2,828 21 528 18.7 91 2,300 81.3
Elementary school 360 8,721 76 1,807 20.7 284 6,914 79.3
Illiterate/Literate 465 10,712 109 2,344 21.9 356 8,368 78.1
Marital status* 0.011
Married 365 9,144 80 1,994 21.8 285 7,150 78.2
Single 178 4,356 28 591 13.6 150 3,765 86.4
Widow/Widower 317 6,793 85 1,754 25.8 232 5,039 74.2
Separated/Divorced 117 2,980 25 616 20.7 92 2,365 79.3
Physical activity 0.153
Yes 149 3,654 26 593 16.2 123 3,061 83.8
No 834 19,762 193 4,386 22.2 641 15,376 77.8
Smoking 0.148
Non-smoker 282 6,696 71 1,618 24.2 211 5,078 75.8
Ex-smoker 537 12,541 119 2,689 21.4 418 9,852 78.6
Smoker 164 4,179 29 672 16.1 135 3,507 83.9
Consumption of alcoholic beverage 0.149
No 857 20,138 185 4,131 20.5 672 16,007 79.5
Yes 80 2,175 23 600 27.6 57 1,575 72.4
N: expanded n from sampling weights and design; %: proportion from N; χ2 = p: Pearson’s chi-squared test; CKD: chronic kidney disease
* The differences in relation to the total are due to the lack of information in the variable.
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This study meets the requirements of Resolution CNS 466/2012, which addresses ethics in 
research involving human beings, and was approved by the Research Ethics Committee of 
the Universidade Federal do Acre, under CAAE: 17543013.0.0000.5010.
RESULTS
The prevalence of CKD was of 21.4%, with verified decreased GFR in 13.0% of older adults and 
the presence of albuminuria in 11.6%. The prevalence of the prognosis with mild, moderate 
and high risk was, respectively, 14.5%, 4.9% and 2.1% (Table 1).
The presence of CKD was higher among octogenarian individuals, with a prevalence of 
almost 40.0%, and among those declared widows/widowers, who showed a prevalence of 
25.9%, with statistically significant differences (Table 2).
In the analysis of the health conditions of older adults with CKD, 29.5% reported considering 
their health bad or very bad, 26.4% were classified as obese, 24.0% had SAH and 22.7% had 
dyslipidemia. Diabetes obtained the highest prevalence, 41.5%, and metabolic syndrome 





n N n N % n N %
Self-assessment of health 0.014
Very good/Regular 824 19,774 170 3,906 19.8 654 15,868 80.2
Bad/Very bad 159 3,642 49 1,073 29.5 110 2,569 70.5
BMI (kg/m2)* 0.031
< 25.0 333 7,844 59 1,275 16.3 274 6,569 83.7
25.0–29.9 367 8,816 83 1,944 22.1 284 6,872 77.9
≥ 30.0 248 5,932 69 1,565 26.4 179 4,367 73.6
Hypertension* 0.008
No 231 5.571 32 728 13.1 199 4,843 86.9
Yes 744 17,618 186 4,231 24.0 558 13,387 76.0
Diabetes* < 0.001
No 820 19,501 152 3,381 17.3 668 16,120 82.7
Yes 161 3,848 67 1,599 41.5 94 2,249 58.5
Dyslipidemia* 0.032
No 198 4,753 32 743 15.6 166 4,010 84.4
Yes 784 18,629 187 4,236 22.7 597 14,393 77.3
Metabolic syndrome* < 0.001
No 618 14,842 105 2,385 16.1 513 12,458 83.9
Yes 356 8,363 111 2,536 30.3 245 5,827 69.7
Other self-reported CVD (CHF, MI, CVA, arrhythmia)* 0.462
No 830 19,834 182 4,132 20.8 648 15,702 79.2
Yes 138 3,219 34 766 23.8 104 2,453 76.2
Use of medicines 0.034
No 231 5,934 42 1,020 17.2 189 4,914 82.8
Yes 752 17,482 177 3,960 22.6 575 13,522 77.4
Hospitalization in the past 12 months* 0.055
No 791 18,869 167 3,843 20.4 624 15,026 79.6
Yes 158 3,769 49 1,077 28.6 109 2,692 71.4
N: expanded n from the sampling weights and design; %: proportion from N; χ2 = p: Pearson’s chi-squared test; BMI: body mass index; CVD: 
cardiovascular diseases; CHF: congestive heart failure; MI: myocardial infarction; CVA: cerebrovascular accident 
* The differences in relation to the total are due to the lack of information in the variable.
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was present in 30.3% of the people classified as having a CKD. The use of medications was 
reported by 22.6% of these older adults (Table 3).
Statistically significant differences were observed in the distribution of CKD in the variables 
self-assessment of health, obesity according to the BMI, SAH, diabetes and dyslipidemia. 
Except for the self-assessment of health, all are components of metabolic syndrome, also 
related. The current use of medications also showed statistically significant difference in 
the presence of CKD (Table 3).
The assessment of odds ratio with the introduction of potentially confusing variables 
observed a statistically significant association between CKD and age group, self-assessment 
of health, obesity, hypertension, diabetes and metabolic syndrome, even after adjustment. 
The model for MS analysis did not include the variables SAH and DM, since they already 
belong to the definer set of the syndrome (Table 4).
DISCUSSION
The prevalence of CKD was high in older adults, being associated with age, self-assessment of 
health as bad or very bad, obesity, diabetes and metabolic syndrome, even after adjustments. 
In this research, the incorporation of objective criteria to standardize the staging of CKD 
(use of GFR according to the formula CKD-EPI and the classification of albuminuria) favored 
the comparison with different locations15.
Table 4. Factors associated to CKD in older adults from Rio Branco, state of Acre, 2014.
Variable ORcrude (95%CI) ORadjusted (95%CI)
Age group (years)
60–69 1 1
70–79 1.64 (1.12–2.40) 1.83 (1.25–2.68)
80 and more 3.20 (2.24–4.57) 3.99 (2.70–5.91)
Self-assessment of health
Very good/Regular 1 1
Bad/Very bad 1.70 (1.12–1.58) 1.79 (1.10–2.91)
BMI (kg/m2)
< 25.0 1 1
25.0–29.9 1.46 (0.95–2.24) 1.37 (0.90–2.08)
≥ 30.0 1.85 (1.11–3.08) 1.69 (1.02–2.80)
Use of medicines
No 1 1
Yes 1.41 (1.03–1.94) 0.70 (0.43–1.14)
Arterial hypertension
No 1 1
Yes 2.10 (1.22–3.63) 1.82 (1.04–3.19)
Diabetes
No 1 1
Yes 3.39 (2.34–4.91) 3.39 (2.13–5.40)
Dyslipidemia
No 1 1
Yes 1.59 (1.04–2.43) 1.43 (0.87–2.37)
Metabolic syndrome*
No 1 1
Yes 2.27 (1.61–3.21) 2.49 (1.71–3.63)
BMI: body mass index; OR: odds ratio; ORcrude: crude analysis; ORadjusted: adjusted analysis by the variables with 
each other
* In the analysis of metabolic syndrome, BMI, dyslipidemia, arterial hypertension and diabetes. 
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The prevalence of CKD increases with advancing age16. The aging process results in reduced 
GFR, which is a normal biological phenomenon linked to cellular and organ senescence, 
resulting from the change in the volume of the kidney, with reduced number of nephrons, 
change in the vasoactive response and changes in the activity of the renin-angiotensin 
systems, associated to the cellular oxidative stress17. Another functional abnormality 
of aging is the increased permeability of the glomerular basement membrane, which 
allows the excretion of a larger number of proteins, including albumin, another factor 
that influences the increase of the prevalence of renal injury in older people18. The decline 
of renal function, which seems to start early in the second decade of life19, was observed 
in this study, with increased prevalence of CKD in each surveyed age group, reaching 
37.8% in octogenarians.
The high prevalence of older adults with CKD, especially those with 70 years or more, 
according to the criteria of the Kidney Disease: Improving Global Outcomes (KDIGO) 2012, 
has been questioned by researches who defend a new definition of CKD for older adults, not 
classifying individuals in stage 3a as sick, but only those with GFR < 45 ml/min/1,73 m² and 
the presence of albuminuria20. This proposal would reduce the prevalence of renal injury 
in this study.
It is worth noting that two-thirds of the elderly population show reduced GFR without 
complications related to health in most cases; however, the presence of chronic conditions 
such as hypertension and diabetes, associated to aging, may lead to the sharp decline 
of renal function, with increased prevalence of CKD21. Different mechanisms are related 
with the physiopathology of CKD associated to SAH, including the deregulation of sodium 
content, renin-angiotensin system and the endothelial function22, which become more 
expressive with age.
In a national survey performed with 7,552 subjects in Italy, the prevalence of CKD in the age 
group from 60 to 69 years was 8.7%, and in the group from 70 to 79, it was approximately 
17.0%, with hypertension associated to the disease (OR = 1.55)23. In a population study in 
Poland with 2,413 participants, the prevalence in the age group of 60 to 79 years was 15.3%, 
with a nearly twice as likely chance of the hypertensive individual being classified as having 
CKD24. In this study, hypertension was also positively associated with CKD.
In addition to hypertension, among the morbidities assessed in this research, diabetes 
obtained a greater association with CKD, which was also observed in other researches23,24. 
Among diabetics, the mechanisms involved in the renal lesion result in glomerular 
hyperfiltration with proteinuria — in most cases, glomerulosclerosis with reduced GFR25. 
In a study on mortality due to CKD in Rio Branco, diabetes and SAH were among the 
associated leading causes of death26.
In this study, bad and very bad self-assessment of health was also related to CKD. 
This assessment is useful as an overall measure of the health status in the general 
population, being consistent with the real state of health. In a population-based 
research performed in China, with individuals with 18 years or more, the presence of 
CKD resulted in a four times greater change of self-report to a poor health condition 
(OR = 4.41; 95%CI 3.20–6.07)27.
Obesity increases the risk of occurrence of diseases considered risk factors for the 
development of CKD, such as SAH and diabetes, in addition to acting in the progression of 
the stages of CKD by hyperfiltration, to meet the demands of the body weights and of the 
increase of the intra-glomerular pressure, which damages renal structures28. Among the 
older adults of this research, obesity defined by BMI, was associated with CKD.
The data analysis of 9,100 adults of the Chronic Renal Disease in Turkey (CREDIT) 
evidenced the association of CKD to obesity, determined by the BMI, and to metabolic 
syndrome (OR = 1.32; 95%CI 1.11–1.57)29. In this research, even after adjustment, the 
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presence of CKD increased more than twice the chance the individual has of having 
metabolic syndrome.
One of the limitations of this research is the possible attenuation of the associations 
observed, due to the effect of survival among older adults. Another factor is the definition of 
CKD by the estimation of the GFR and albuminuria from a blood and urine punctual sample, 
since it is recognized that the confirmation of the disease occurs when the abnormality in 
GFR or albuminuria for a period of three months. In addition, the choice of more than one 
individual of a same household may result in the reduction of variability. It is necessary to 
emphasize, also, that the exclusion of individuals without physical or cognitive capacity 
to participate in the study may lead to errors in the estimation of the GFR, since these are 
more likely to reduce this rate.
Finally, the importance of population surveys stands out as an important source of 
information on the health of the older adult population, aimed at the definition of risk 
factors and the prevention of diseases or their complications. Finding the disease in its 
early stages among older adults must be a priority in Northern Brazil, which has an aging 
index that went from 8.2% in 1970 to 24.6% in 2010, in addition to the increase of chronic 
morbidities such as diabetes, SAH and obesity30, factors associated to CKD.
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